CTOs on the Move

MedServe

www.medserve.com

 
MedServe is a Bellaire, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.medserve.com
  • 6565 West Loop S Ste 400
    Bellaire, TX USA 77401
  • Phone: 713.580.4000

Executives

Name Title Contact Details

Similar Companies

Fitness by Fronk

Fitness by Fronk is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Behavioral Health Consulting Solutions

Behavioral Health Consulting Solutions (BHCS) is a company that provides behavioral health evaluations and services. They offer online therapy in Montana and in-person services at their Belgrade, MT office.

Acupuncture Atlanta

Select from over 12,000 Chinese herbs and nutritional supplements including doctor trusted brands * Discounts up to 25% * Free 15 minute consultations available

WellPath Solutions

Achieve your health and wellness goals with our customized, expertly-formulated nutritional supplements and vitamins. Try WellPath today!

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.